GRAIL Inc. Common Stock (GRAL)
GRAL trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$140.35
+2.17% on the day
Market cap
$6.3B
Mid cap
Revenue · 2025
$147.2M
+17.2% on 2024
Net income · 2025
-$408.4M
-277.5% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | GRAL on Nasdaq |
| Sector | Health Care |
| Industry | Medical Specialities |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001699031 |
| SEC industry code | Services-Medical Laboratories |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $147.2M |
| Net income | -$408.4M |
| Operating income | -$562.2M |
| Net margin | -277.5% |
| Operating margin | -382.0% |
| Revenue growth | +17.2% |
| Cash | $249.7M |
| Total assets | $2.9B |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 42.6× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2025-11-14 |
| Latest annual report | 10-K | 2026-03-12 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report | 8-K | 2026-08-05 |
| Latest proxy | DEFA14A | 2026-04-28 |
Source: SEC EDGAR submissions feed, 258 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +4.6% |
| 1 month | +83.1% |
| 3 months | +93.1% |
| Year to date | +62.4% |
| 1 year | +97.3% |
| From 52-week high | -9.8% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical Specialities
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| RDNT | RadNet Inc. | $71.51 | +0.03% | $5.6B |
| CON | Concentra Group Holdings Parent Inc. | $37.54 | 0.00% | $4.8B |
| CAI | Caris Life Sciences Inc. | $29.53 | -0.54% | $8.3B |
| BLLN | BillionToOne Inc. | $94.44 | +1.47% | $4.5B |
| HSIC | Henry Schein Inc. | $85.03 | +0.95% | $9.5B |
| OSCR | Oscar Health Inc. | $33.79 | -0.65% | $10.4B |
| MOH | Molina Healthcare Inc | $209.50 | +2.52% | $10.9B |
| VCYT | Veracyte Inc. | $43.11 | -2.07% | $3.5B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier